CTD Holdings to Present at WORLD Symposium on Lysosomal Storage Diseases
ALACHUA, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today announced acceptance of two …